Cotización HCW Biologics - HCWB

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

0.89

Postura de Compra

0.89

Postura de Venta

0.91

Volume Operado de la Acción

7,173,717

0.81 Rango del Día 1.11

0.2761 Rango de 52 semanas 2.52

Capitalización de Mercado [m]

33.663M

Precio Anterior

1.10

Precio de Apertura

0.93

Hora

0.91

Última hora de negociación

Volumen financiero

US$ 7,164,788

Precio Promedio Ponderado

0.998755

Volumen promedio (3 m)

9,516,063

Acciones en circulación

37,823,394

Rendimiento del Dividendo

Ratio Precio/Utilidad

-1.44

Beneficio por acción (BPA)

-0.66

turnover

2.84M

Beneficio neto

-24.99M

HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a signi... HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.hcwbiologics.com

Sede

Wilmington, Delaware, USA

Fundado

HCW Biologics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HCWB. The last closing price for HCW Biologics was US$1.10. Over the last year, HCW Biologics shares have traded in a share price range of US$ 0.2761 to US$ 2.52.

HCW Biologics currently has 37,823,394 shares in issue. The market capitalisation of HCW Biologics is US$41.61 million. HCW Biologics has a price to earnings ratio (PE ratio) of -1.44.

Form 8-K - Current report

Form 424B2 - Prospectus [Rule 424(b)(2)]

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

MIRAMAR, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0.5876	194.312169312	0.3024	2.52	0.2761	111724941	1.22744853	CS
4	0.335	60.3603603604	0.555	2.52	0.2761	28016772	1.22477216	CS
12	0.4093	85.1466611192	0.4807	2.52	0.2761	9516063	1.22344486	CS
26	-0.26	-22.6086956522	1.15	2.52	0.2761	4395154	1.22253685	CS
52	-0.25	-21.9298245614	1.14	2.52	0.2761	2240253	1.22293145	CS
156	-2.05	-69.7278911565	2.94	3.32	0.2761	770959	1.25174634	CS
260	-6.61	-88.1333333333	7.5	7.51	0.2761	923457	2.10360006	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
FBRXForte Biosciences Inc	US$ 13.60 (129.53%)	28.92M
QSIQuantum Si Inc	US$ 1.39 (119.59%)	279.33M
XCURExicure Inc	US$ 11.01 (89.18%)	22.91M
AGFYAgrify Corporation	US$ 37.4635 (68.00%)	921.45k
SLXNSilexion Therapeutics Corporation	US$ 0.3495 (54.51%)	198.66M
SKKSKK Holdings Limited	US$ 4.55 (-47.28%)	816.93k
QMMMQMMM Holdings Limited	US$ 0.713999 (-43.78%)	4.61M
XTKGX3 Holdings Company Ltd	US$ 0.0901 (-37.82%)	5.95M
PRFXPainReform Ltd	US$ 1.02 (-27.14%)	5.09M
GLEGlobal Engine Group Holding Ltd	US$ 3.81 (-26.59%)	230.23k
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.191 (17.39%)	662.68M
DBGIDigital Brands Group Inc	US$ 0.1345 (15.35%)	326.45M
NVDANVIDIA Corporation	US$ 145.89 (-0.76%)	309.57M
QSIQuantum Si Inc	US$ 1.39 (119.59%)	283.09M
SLXNSilexion Therapeutics Corporation	US$ 0.3495 (54.51%)	200.06M